Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1/2 × Enrolling by invitation × Melphalan × Clear all

Phase

Phase 3 1 Phase 1/2 1

Status

Completed 45 Terminated 11 Withdrawn 6 Active not recruiting 6 Unknown 5 Recruiting 4 Enrolling by invitation 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Uveal Melanoma 1 Melanoma 1

Interventions

Lenalidomide 2 irinotecan sucrosofate 1 enzalutamide 1 Ruthenium-106 1 Radiotherapy 1 Melphalan 1 Mannitol 1 Leukocyte Count 1 Irinotecan 1 Folfox protocol 1 Dexamethasone 1 Cyclophosphamide 1 Carboplatin 1 Brachytherapy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05893654 2025-09-15

MELCOM

Hospital das Clínicas de Ribeirão Preto

Phase 1/2 Enrolling by invitation

Uveal Melanoma, Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡